Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Thrombosis Research|April 29, 2006
Lipoprotein (a) in patients with spontaneous venous thromboembolismRainer Vormittag, Thomas Vukovich, Milena Stain, et al.Haematologica|March 7, 2007
Venous thromboembolism--a manifestation of the metabolic syndromeCihan Ay, Theres Tengler, Rainer Vormittag, et al.Thrombosis and Haemostasis|March 1, 2005
Basal high-sensitivity-C-reactive protein levels in patients with spontaneous venous thromboembolismRainer Vormittag, Thomas Vukovich, Verena Schönauer, et al.Haematologica|November 4, 2005
Haptoglobin phenotype 2-2 as a potentially new risk factor for spontaneous venous thromboembolismRainer Vormittag, Thomas Vukovich, Christine Mannhalter, et al.Thrombosis and Haemostasis|October 17, 2007
The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control studyCihan Ay, Peter Bencur, Rainer Vormittag, et al.Antimicrobial Agents and Chemotherapy|March 30, 2006
Impaired target site penetration of vancomycin in diabetic patients following cardiac surgeryKeso Skhirtladze, Doris Hutschala, Tatjana Fleck, et al.Diabetes Care|August 31, 2004
Haptoglobin phenotype and gestational diabetesStefan Mustafa, Thomas Vukovich, Thomas Prikoszovich, et al.The Journal of Rheumatology|March 3, 2005
Inflammation in patients with lupus anticoagulant and implications for thrombosisThomas Sailer, Rainer Vormittag, Ingrid Pabinger, et al.Journal of Clinical Laboratory Analysis|November 21, 2009
Increased soluble serum markers caspase-cleaved cytokeratin-18, histones, and ST2 indicate apoptotic turnover and chronic immune response in COPDStefan Hacker, Christopher Lambers, Andreas Pollreisz, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|January 4, 2011
Increased total cytokeratin-18 serum and urine levels in chronic kidney diseaseGeorg A Roth, Diana Lebherz-Eichinger, Hendrik Jan Ankersmit, et al.Pageof 1